Stock listing
NASDAQ:ABOS Acumen Pharmaceuticals, Inc. Stock
Home listing (NASDAQ) of Acumen Pharmaceuticals, Inc.
Follow Acumen Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ABOS
$0.234 USD -0.005 (-2.2%)
Close on Nov 3, 2026
- Day range
- $0.225 – $0.248 USDNov 3, 2026
- Volume
- 6.01M sharesNov 3, 2026
- Market cap
- $16.95M USDAt the close on Nov 3, 2026 · price × 72.33M shares outstanding
- 52-week range
- $0.198 – $3.600 USDLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
- Traded on an average day
- $1.56M USDMedian day 450,800 shares · last 3 months, Aug 3, 2026 – Nov 3, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ABOS · Home | $0.234 USD | -0.005 (-2.2%) | 6,015,000 | $0.240 | $0.248 | $0.225 | $0.240 | Close on Nov 3, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 3, 2026 · NASDAQ:ABOS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.234 | -0.005 | -2.2% | $0.240 | $0.248 | $0.225 | 6,015,000 | |
| $0.240 | +0.030 | +14.1% | $0.201 | $0.267 | $0.198 | 33,691,309 | |
| $0.210 | -2.080 | -90.8% | $0.344 | $0.352 | $0.209 | 66,552,400 | |
| $2.290 | -0.090 | -3.8% | $2.400 | $2.520 | $2.285 | 807,400 | |
| $2.380 | +0.120 | +5.3% | $2.280 | $2.495 | $2.257 | 1,407,800 | |
| $2.260 | -0.010 | -0.4% | $2.250 | $2.370 | $2.100 | 1,797,500 | |
| $2.270 | +0.290 | +14.6% | $2.130 | $2.420 | $1.970 | 1,646,800 | |
| $1.980 | -0.080 | -3.9% | $2.050 | $2.050 | $1.895 | 541,800 | |
| $2.060 | +0.030 | +1.5% | $2.030 | $2.140 | $2.010 | 569,500 | |
| $2.030 | +0.015 | +0.7% | $2.000 | $2.080 | $1.990 | 397,600 | |
| $2.015 | +0.245 | +13.8% | $1.780 | $2.070 | $1.764 | 784,300 | |
| $1.770 | +0.080 | +4.7% | $1.700 | $1.780 | $1.670 | 274,600 | |
| $1.690 | +0.020 | +1.2% | $1.670 | $1.715 | $1.620 | 449,300 | |
| $1.670 | -0.075 | -4.3% | $1.710 | $1.755 | $1.660 | 602,500 | |
| $1.745 | -0.070 | -3.9% | $1.810 | $1.870 | $1.710 | 619,800 | |
| $1.815 | -0.205 | -10.1% | $2.000 | $2.000 | $1.810 | 646,100 | |
| $2.020 | -0.120 | -5.6% | $2.140 | $2.140 | $2.000 | 291,500 | |
| $2.140 | +0.040 | +1.9% | $2.120 | $2.170 | $2.081 | 357,500 | |
| $2.100 | 0.000 | 0.0% | $2.090 | $2.135 | $2.020 | 505,200 | |
| $2.100 | +0.070 | +3.4% | $2.020 | $2.170 | $2.000 | 623,100 | |
| $2.030 | -0.100 | -4.7% | $2.130 | $2.140 | $2.000 | 562,900 | |
| $2.130 | +0.090 | +4.4% | $2.040 | $2.160 | $2.015 | 713,900 | |
| $2.040 | -0.030 | -1.4% | $2.100 | $2.100 | $2.015 | 580,500 | |
| $2.070 | -0.150 | -6.8% | $2.220 | $2.290 | $2.070 | 832,800 | |
| $2.220 | -0.025 | -1.1% | $2.250 | $2.450 | $2.100 | 1,482,700 | |
| $2.245 | -0.055 | -2.4% | $2.300 | $2.420 | $2.220 | 1,086,800 | |
| $2.300 | +0.060 | +2.7% | $2.220 | $2.375 | $2.190 | 856,300 | |
| $2.240 | +0.005 | +0.2% | $2.250 | $2.295 | $2.220 | 235,300 | |
| $2.235 | -0.070 | -3.0% | $2.300 | $2.340 | $2.220 | 265,800 | |
| $2.305 | -0.345 | -13.0% | $2.630 | $2.630 | $2.300 | 467,900 | |
| $2.650 | +0.060 | +2.3% | $2.610 | $2.705 | $2.600 | 567,700 | |
| $2.590 | -0.060 | -2.3% | $2.630 | $2.645 | $2.555 | 395,200 | |
| $2.650 | +0.080 | +3.1% | $2.550 | $2.670 | $2.515 | 889,900 | |
| $2.570 | -0.040 | -1.5% | $2.690 | $2.760 | $2.535 | 490,000 | |
| $2.610 | -0.280 | -9.7% | $2.920 | $2.950 | $2.590 | 369,000 | |
| $2.890 | +0.100 | +3.6% | $2.770 | $2.900 | $2.690 | 359,300 | |
| $2.790 | -0.130 | -4.5% | $2.910 | $3.015 | $2.780 | 394,200 | |
| $2.920 | +0.060 | +2.1% | $2.930 | $2.985 | $2.840 | 318,200 | |
| $2.860 | +0.010 | +0.4% | $2.790 | $2.900 | $2.730 | 467,800 | |
| $2.850 | -0.310 | -9.8% | $3.140 | $3.160 | $2.840 | 369,200 | |
| $3.160 | -0.020 | -0.6% | $3.140 | $3.290 | $3.075 | 358,100 | |
| $3.180 | +0.090 | +2.9% | $3.070 | $3.230 | $3.030 | 315,400 | |
| $3.090 | -0.010 | -0.3% | $3.130 | $3.165 | $3.050 | 452,300 | |
| $3.100 | +0.180 | +6.2% | $2.930 | $3.125 | $2.930 | 247,300 | |
| $2.920 | +0.070 | +2.5% | $2.800 | $2.950 | $2.800 | 188,900 | |
| $2.850 | -0.070 | -2.4% | $2.900 | $2.920 | $2.760 | 244,200 | |
| $2.920 | -0.110 | -3.6% | $3.020 | $3.020 | $2.885 | 305,800 | |
| $3.030 | +0.040 | +1.3% | $2.980 | $3.170 | $2.980 | 270,800 | |
| $2.990 | -0.110 | -3.5% | $3.090 | $3.090 | $2.915 | 235,000 | |
| $3.100 | +0.025 | +0.8% | $3.090 | $3.169 | $3.040 | 300,700 | |
| $3.075 | -0.085 | -2.7% | $3.170 | $3.170 | $3.040 | 276,000 | |
| $3.160 | -0.030 | -0.9% | $3.210 | $3.340 | $3.135 | 715,800 | |
| $3.190 | +0.040 | +1.3% | $3.120 | $3.245 | $3.010 | 599,700 | |
| $3.150 | +0.410 | +15.0% | $2.790 | $3.170 | $2.790 | 617,800 | |
| $2.740 | +0.080 | +3.0% | $2.660 | $2.790 | $2.636 | 309,400 | |
| $2.660 | -0.010 | -0.4% | $2.660 | $2.740 | $2.620 | 412,800 | |
| $2.670 | +0.120 | +4.7% | $2.510 | $2.695 | $2.450 | 526,700 | |
| $2.550 | +0.040 | +1.6% | $2.500 | $2.550 | $2.390 | 449,100 | |
| $2.510 | +0.040 | +1.6% | $2.410 | $2.590 | $2.400 | 487,100 | |
| $2.470 | +0.040 | +1.6% | $2.440 | $2.500 | $2.420 | 204,600 | |
| $2.430 | -0.010 | -0.4% | $2.410 | $2.450 | $2.370 | 194,400 | |
| $2.440 | +0.160 | +7.0% | $2.290 | $2.440 | $2.290 | 256,800 | |
| $2.280 | +0.040 | +1.8% | $2.240 | $2.340 | $2.230 | 228,200 | |
| $2.240 | 0.000 | 0.0% | $2.260 | $2.295 | $2.220 | 298,100 | |
| $2.240 | +0.060 | +2.8% | $2.180 | $2.270 | $2.180 | 283,400 | |
| $2.180 | +0.030 | +1.4% | $2.170 | $2.210 | $2.110 | 227,300 |
- Ticker
- NASDAQ:ABOS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 30, 2026
Acumen Pharmaceuticals Announces Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193) for the Treatment of Early Alzheimer’s Disease; Trial Did Not Meet Primary Endpoint
Latest earnings call · Oct 26, 2026
Acumen Pharmaceuticals (NASDAQ:ABOS) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 26, 2026
Investor Presentation (October 2026)
Investor deck · 49 slides
Calls
Replays
Acumen Pharmaceuticals (NASDAQ:ABOS) Q3 2026 Earnings Call
Mon, Oct 26, 2026 · 8:00 AM ET
Watch TranscriptAcumen Pharmaceuticals (NASDAQ:ABOS) Q2 2026 Earnings Call
Wed, Aug 12, 2026 · 8:00 AM ET
Watch TranscriptAcumen Pharmaceuticals (NASDAQ:ABOS) Q1 2026 Earnings Call
Tue, May 12, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Acumen Pharmaceuticals Announces Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193) for the Treatment of Early Alzheimer’s Disease; Trial Did Not Meet Primary Endpoint
Oct 30, 2026
Closed $0.21 (-90.8%) on Oct 30, 2026
Acumen Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Highlights
Oct 26, 2026
Closed $2.27 (+14.6%) on Oct 26, 2026
Acumen Pharmaceuticals to Present Preliminary Baseline Characteristics and Data on Care Experiences and Participation in Phase 2 ALTITUDE-AD Trial at the 19th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Oct 22, 2026
Closed $2.06 (+1.5%) on Oct 22, 2026
Acumen Pharmaceuticals to Report Third Quarter Financial Results on October 26, 2026
Oct 19, 2026
Closed $2.02 (+13.8%) on Oct 20, 2026
Acumen Pharmaceuticals to Hold Virtual Investor Day on September 16, 2026
Sep 10, 2026
Closed $2.92 (+2.1%) on Sep 11, 2026
Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights
Aug 12, 2026
Closed $2.51 (+1.6%) on Aug 12, 2026
Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 12, 2026
Aug 5, 2026
Closed $2.28 (+1.8%) on Aug 6, 2026
Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026
Jul 15, 2026
Closed $2.22 (-12.3%) on Jul 15, 2026
Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease
Jun 16, 2026
Closed $2.29 (-2.1%) on Jun 16, 2026
Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights
May 12, 2026
Closed $2.48 (-3.5%) on May 12, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 49 slides · Oct 26, 2026
Investor Day (September 2026)
Investor day · 59 slides · September 2026
Q2 2026 Earnings Presentation
Earnings · 58 slides · Aug 12, 2026
AAIC 2026
Conference · 12 slides · Jul 12, 2026
Acumen Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 26 in the last 12 months · 83 in all · newest Oct 30, 2026 · oldest 2021
- Calls
- 20 calls with a replay · 20 with a transcript · latest Oct 26, 2026
- Decks
- 45 decks · latest Oct 26, 2026
Where Acumen Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ABOS · Home listing · This page | NASDAQ | United States | USD |
| BOATS:ABOS | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Acumen Pharmaceuticals, Inc.